MedTrace Logo

Supplement Combination on Stress and Sleep

NCT06889584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2026-02-11

No results posted yet for this study

Summary

The purpose of this clinical trial is to assess the effects of a supplement combination on measures of sleep quality and stress in healthy adults.

Conditions

  • Healthy

Interventions

OTHER

AM and PM Placebo

Placebo AM and PM

COMBINATION_PRODUCT

All Active Supplement Combinations (Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin))

Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin.

COMBINATION_PRODUCT

AM Active Supplement Combination (Ashwagandha and Rhodiola rosea)

Ashwagandha and Rhodiola rosea

COMBINATION_PRODUCT

PM Active Supplement Combination (Magnesium threonate, L-theanine, and apigenin)

Magnesium threonate, L-theanine, and apigenin.

Sponsors & Collaborators

  • Momentous

    collaborator UNKNOWN

  • University of South Carolina

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-15
Primary Completion
2025-12-01
Completion
2026-02-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06889584 on ClinicalTrials.gov